Seite Ebene 4 a

Direktlink:
Inhalt; Accesskey: 2 | Servicenavigation; Accesskey: 4
 

You are here:

Alternative Methods to Animal Testing for the Detection of Endocrine Disruptors in vitro

A reliable assessment of the effects of chemicals and pesticides on the human endocrine system (so-called endocrine disruptors) is of central importance for consumer health protection. Hormones regulate, among other things, the formation, breakdown and remodeling of various organs and tissues. If these precisely regulated processes get out of balance, this can lead to the development of tumors and metastases. In the case of breast cancer, which is one of the most common types of cancer in Germany, the female hormone estrogen plays an important role in this context, as it is suspected of promoting tumor formation and metastasis.

The E-Morph Assay - a cell-based screening method for reliable identification of substances with estrogenic effects

Until now, the identification and characterization of endocrine disruptors has been based primarily on animal experiments, whereby a high number of test animals (>500 per substance) is required, especially for the detection of carcinogenic effects. Here, alternative methods, such as a cell-based screening method (E-Morph Assay) that is developed in this project, can support the reliable identification of substances with estrogenic effects and thus help to significantly reduce the number of test animals. The Bf3R is also investigating possible molecular mechanisms of action of endocrine disruptors using biochemical methods and super-resolution microscopy. A special focus is on the influence of estrogenic substances on tissue stability and tumor metastasis.

The Bf3R thus contributes to the scientific discussion on how chemicals and pesticides in the environment can affect the human endocrine system and whether there is a possible health risk.

Grafik zum Nachweis hormonaktiver Wirkungen

Workflow (exposure - image analysis - prediction) of a cell-based screening method to identify substances with estrogenic effects.

In a 96-well plate, cells of a breast cancer cell line are brought into contact with various test substances in increasing concentrations (exposure). These cells are then stained with a dye, which can be used to derive various morphological parameters for each individual cell (image analysis). Based on these parameters, dose-response curves can be generated, which provide information about a potential estrogenic effect of a test substance (prediction).

Further reading:

Klutzny, S.; Kornhuber, M.; Morger, A.; Schönfelder, G.; Volkamer, A.; Oelgeschläger, M.; Dunst, S. Quantitative high-throughput phenotypic screening for environmental estrogens using the E-Morph Screening Assay in combination with in silico predictions. Environment International 2022;158:106947 https://www.sciencedirect.com/science/article/pii/S0160412021005729

Kornhuber, M.; Dunst, S.; Schönfelder, G.; Oelgeschläger, M. The E-Morph Assay: Identification and characterization of environmental chemicals with estrogenic activity based on quantitative changes in cell-cell contact organization of breast cancer cells. Environment International 2021;149:106411. https://www.sciencedirect.com/science/article/pii/S0160412021000350

Bischoff, P.; Kornhuber, M.; Dunst, S.; Zell, J.; Fauler, B.; Mielke, T.; Taubenberger, A.V.; Guck, J.; Oelgeschläger, M.; Schönfelder, G. Estrogens Determine Adherens Junction Organization and E-Cadherin Clustering in Breast Cancer Cells via Amphiregulin. iScience 2020;23:101683. https://www.sciencedirect.com/science/article/pii/S2589004220308750

Bischoff P, Kornhuber M, Schönfelder G, Oelgeschläger M, Dunst S, Vogl S. Screening method for estrogenic and anti-estrogenic activity. EP3517967, WO/2019/145517, US20210055311. European Patent Office / U.S. Patent & Trademark Office. 2019 / 2021. https://patentscope.wipo.int/search/en/detail.jsf?docId=EP249469531&_fid=WO2019145517

Up

Contact

Visitors' address
Diedersdorfer Weg 1
D - 12277 Berlin

Postal address
Postfach 12 69 42
D - 10609 Berlin

Tel.
+49-30-18412-29000
+49-30-18412-29001

Fax
+49-30-18412-29099

E-Mail
bf3r@bfr.bund.de

Cookie Notice

This site only uses cookies to offer you a better browsing experience. Find out more on how we use cookies in our Data Protection Declaration.